Anti-PD-1 therapy achieves favorable outcome in gastric cancer combined with chronic hepatitis B

Anti-PD-1 therapy achieves favorable outcome in gastric cancer combined with chronic hepatitis B

Abstract Purpose To investigate the efficacy and safety of immune checkpoint inhibitors in the treatment of gastric cancer patients with different hepatitis B virus (HBV) infection statuses. Patients and methods The clinical data of 89 gastric cancer patients treated at our centre were retrospective...

Full description

Saved in:
Bibliographic Details
Main Authors: Lingyan Wang, Fei Yang, Qinhui Dong, Tao-Hsin Tung, Junyan Ye, Kaili Cen, Yupei Yang, Jingjing Xie, Qunyi Guo
Format: Article
Language:English
Published: BMC 2025-08-01
Series:BMC Cancer
Subjects:
HBV infection
Immune checkpoint inhibitors
Gastric cancer
Efficacy
Online Access:https://doi.org/10.1186/s12885-025-14776-8
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12885-025-14776-8

Similar Items